This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Atropos Health , renowned for its evidence-based medicine, is expanding its award-winning Evidence Platform to redefine lifesciences applications. The company has added Dr. Sean Khozin, MD, MPH and Gerry McDougall to its LifeSciences Advisory Board, strengthening its growth in the field.
INITIATE invests in and co-founds transformative companies at the intersection of healthcare, lifesciences, and technology. INITIATEs team deeply understands the challenges and opportunities that health tech and lifesciences companies face. The firm invests in startups poised to make a lasting impact.
Companies will have access to real-world patient data for clinical decision-making and research support, including hypothesis testing and cohort analysis.
Humbi AIs Actuarial Intelligence will be an integral component of Innovaccers Healthcare Intelligence Cloud , unlocking new opportunities for providers, payers, and lifesciences organizations. For more information, visit innovaccer.com.
The following is a guest article by Alex Long, Head of LifeSciences Sales Strategy at Dell Technologies In science, avoiding correlation without causation is a cornerstone of research methodology. About Alex Long Alex Long is the Head of LifeSciences Sales Strategy at Dell Technologies.
The funding will support Briya’s mission to transform how data is exchanged between healthcare organizations and lifesciences organizations, with particular emphasis on supporting the United States health ecosystem. The company’s scalable data exchange platform enables hospitals to capitalize on their patient data.
The following is a guest article by Steven Lazer, Global Healthcare & LifeSciences CTO, Alex Long, Head of LifeSciences Sales Strategy, and Michael Giannopoulos, Healthcare Global CISO and CTO for the Americas at Dell Technologies. Artificial intelligence (AI) has been around for a long time.
The new service, which is now available in preview, was designed to help healthcare and lifesciences organizations aggregate […]. Amazon HealthLake, which AWS describes as “HIPAA-eligible,” was launched during Amazon’s annual re:Invent conference.
The data generated by AI can facilitate early disease detection, personalized medications and care, the prevention of diagnostic or prescription interaction errors, analysis of treatment risks, and much more.
And that data will be generated from many sources, frequently siloed and decentralized which can prevent aggregation, mash-up, and analysis. The Swiss Re table calls out five stakeholder groups, one of which was not called out in the McKinsey analysis: collaborating with consumers/patients.
A recent Frost & Sullivan analysis entitled, Innovative Business Models Powering the Telehealth Market in Europe, has found that the impact of COVID-19 on the healthcare sector across Europe has significantly expanded the use of telehealth. WHY IT MATTERS. ON THE RECORD.
Labviva’s B2B e-commerce marketplace enables lifesciences and research organizations to manage organizational purchasing and procurement to accelerate the pace of lifescience research. We’re thrilled to support Labviva, as they revolutionize the lifesciences procurement industry.
As the exclusive Rainbird service partner in lifesciences, Klick will pair its industry-leading knowledge, data, and tools with Rainbird’s decision intelligence automation platform to eliminate organizational bottlenecks and maximize opportunities for biopharmaceutical organizations bringing life-saving therapies to market.
We investigated many routes to scale our business to deliver our mission and were delighted by Bayer’s invitation to deepen our partnership, whilst continuing to operate independently based on Bayer’s well-established arm’s length model,” said Ben Panter, Chief Executive Officer, Blackford Analysis.
“Tuva Healths open data model solves the transparency issues found in other platforms and encourages collaborative analysis, allowing organizations to take control of their data. With this, we are accelerating clinical research, evidence-based decision-making, and AI advancements all while reducing costs and increasing transparency.
Optra Health, which produces AI-driven iPhronesis analysis platform for healthcare and lifesciences clients, today announced the launch of a new genetics-focused product specially designed for consumers, genetic counselors, and other genomics researchers.
This graphic illustrates that about one-half of companies listed on the S&P have a direct impact on people’s health: think pharma, lifesciences, medical technology, health insurance, food, and transportation. The bar chart illustrates the result of the meta-analysis which considered 148 studies on mortality and risk factors.
Komodo Health, a health data company, has announced a new all-in-one offering for healthcare and lifesciences companies to generate analytical insights. | MapLab includes robust data science tooling, customizable analytics dashboards and a generative AI analytic assistant.
Fujitsu, Toppan tie up for big data analysis Japanese companies Fujitsu and Toppan have entered into a business alliance to offer advanced big data analysis services for hospital organisations and pharmaceutical companies.
Thus, SAS Health Solutions offers a common data model, ingesting data from disparate sources of FHIR data into the appropriate fields for analysis. Gail Stephens, VP, Health and LifeSciences, explains the uses for SAS Health in this video, her goal being to “get patients to better health, more quickly.”
With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the lifesciences and healthcare sector. Please visit astrazeneca.com and follow the Company on Social Media @ AstraZeneca. Available at: [link]. Accessed November 2023.
As healthcare organizations continue to invest in SDoH, moving from analysis to impact requires operationalizing this data for coordinated efforts and long-term returns on investment. There’s a strong emphasis and substantial funds are being spent in this area of healthcare – and it’s not slowing down.
For example, a specialty-tuned large language model (LLM) can help increase the accuracy of domain-specific data so they can ultimately be used for claims and outcomes analysis. AI methods also help create operational efficiencies in cleaning and normalizing large data sets with high accuracy making this data usable for downstream processes.
The acquisition expands Linus Health’s operations into the lifesciences industry. Aural Analytics’ speech analytics software, called Speech Vitals, is used by leading healthcare systems and lifescience organizations in pharmaceutical research and clinical trials.
The results will inform new strategies for personalized Parkinson’s disease management, support tools for the treating clinicians, aiming to enhance quality of life for patients. These findings will now undergo detailed analysis as Newel Health prepares to present the full study results, expected in Q1 2025.
The newly appointed board members are: Jennifer Chavez, Senior Director, BioMed Realty Provides comprehensive commercial real estate transaction expertise and specialized business management services for BioMed Realtys Colorado portfolio, including the 23-building Flatiron Park, a hub for lifescience, quantum and technology innovation.
The new company aims to leverage its extensive data sets and technology to provide innovative solutions across various healthcare sectors, including lifesciences, provider, imaging, health plan, employer, and government health and human services. Subscribe Today! Subscribe Today!
“We are excited to provide this capital to support ImpediMed’s continued mission to improve the lives of patients by pushing the boundaries of what’s possible in fluid and tissue analysis.”
The following is a guest article by Steve Lazer, Global Healthcare & LifeSciences CTO at Dell Technologies. The primary use cases for cognitive AI in biotech include accelerating data analysis, automating document management, improving collaboration, and reducing risk of human error.
Doesn’t it look and feel like a similar drawing from any health care organization’s ESG filing, whether health plan, health provider, or lifescience company? I’m particularly struck by the five pie-chart elements of physical health, mental health, social health, home health, and accessible health.
Pega has been offering analysis and workflow solutions for 40 years, and have put more focus on healthcare lately. The company has clients among providers and lifesciences too. Now they offer payers a wide range of solutions to automate elements of acquisitions, onboarding, engaging with members, and more.
The following is a guest article by Steve Lazer, Global Healthcare & LifeSciences CTO at Dell Technologies. In The healthcare and lifesciences (HCLS) industry deals with extremely sensitive information that can have a direct impact on human lives, such as incorrect dosage recommendations and drug manufacturing defects.
” For this report, PwC’s Health Research Institute surveyed 2,511 American consumers, 128 health plan executives, 153 healthcare provider organization executives, and 124 pharmaceutical and lifesciences executives in August and September 2020. ” the report read. “Quite a bit, it turns out.
By leveraging AI and big data analysis, the company aims to streamline the drug discovery process, making it faster, cheaper, and more predictable. Check our our video interview below to learn more about AION Labs approach to innovation in pharma and lifesciences.
Funding will Support Expanded Commercialization Efforts for PreciseBreast Risk Assessment PreciseDx , a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for new, morphology-driven disease analysis, today announced that it has raised $20.7 million in Series B funding, bringing its total funding to date to $31.5
This article focuses on the technology that ensures quality in the process, and is based on a conversation with Graziella Piras, PhD, LifeScience Business Development Director at 908 Devices. 908 Devices offers a broad spectrum of products for chemical and biochemical analysis.
The following is a guest article by Subhro Mallik, SVP and Head of LifeSciences business unit at Infosys. A meta-analysis conducted some years ago found that patients subjected to digital interventions reported a 39 percent reduction in adverse cardiovascular outcomes, compared to others.
She said they have already conducted an interim analysis using UBAR and have computed a predictive score most likely to result in a pregnancy. Enterprise Taxonomy: Telehealth LifeSciences AI Digital Health Patient Access Care Analytics Technology. "This method is simple and inexpensive," she claimed.
Here is a de ep analysis from GoodRx on the launch of at least 9 Humira biosimilars for 2023, foretelling this one product alone could have a major impact on the overall cost of prescription drugs in the U.S. In 2023, the Humira biosimilar launch is seen as a “new milestone” for biosimilars in the U.S. for 2024 medical trend.
The following is a guest article by Ganesh Nathella, Senior Vice President & General Manager – Healthcare and LifeSciences Business at Persistent Systems The rapid integration of digital technologies in healthcare has revolutionized patient care and operations, but it has also heightened concerns about data privacy.
" The solution is also expected to have the ability to integrate with multiple data sources and enable automated data cleaning, analysis, and reporting.
Translation: watch out for winter and flu season, especially if people don’t re-mask and take care to protect themselves and others — particularly important in geographies where more folks have opted out of getting vaccinated.
With over 400 footnotes and 300+ pages of analysis, the good doctors gleaned over T1,000 scientific abstracts and 250 research papers. The wordle shown here published in the book demonstrates that “Compassionomics” is a field that is so new there was no single search term to use for curating this research.
About Flywheel Flywheel is the pioneering medical imaging data and AI platform powering healthcare innovation through streamlined medical imaging data management, curation, and analysis. Flywheel helps organizations turn complex imaging data into analysis-ready datasets for accelerated research and AI development.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content